(Circulation. 1999;100:e149.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
Department of Geriatrics and Metabolic Diseases and Institute of Pharmacology, Second University of Naples, Piazza Miraglia, Naples, Italy
| Introduction |
|---|
|
|
|---|
QTc dispersion is an important predictor of cardiac mortality. In the Rotterdam Study,1 persons in the highest tertile (>60 ms) relative to the lowest tertile (<39 ms) of QTc dispersion had a 2-fold risk of cardiac death. The Rotterdam Study also confirms that QTc dispersion is larger in diabetic than in nondiabetic persons. QTc duration and QTc dispersion are associated with plasma glucose and insulin levels,2 but their relative contributions to each are still unclear. We evaluated the effect of acute hyperglycemia, with or without the accompanying hyperinsulinemia, on QTc duration and QTc dispersion in normal subjects.
We studied 27 healthy volunteers (17 men and 15 women) aged 49±6 years
(mean±SD). All subjects were given a hyperglycemic glucose clamp in
which plasma glucose concentrations were acutely raised with a bolus
injection of 0.33 g/kg glucose (50% solution) followed by a 30%
glucose infusion to achieve steady-state plasma glucose levels of
15 mmol/L for 120 minutes. On another occasion, which was
separated from the first by at least a 3-day interval and in random
order, the subjects underwent the same hyperglycemic clamp plus
octreotide administration (25 µg as IV bolus followed by a 0.5
µg/min infusion) to block the release of endogenous
insulin. All tests were made with the aid of an artificial pancreas
(Biostator). Electrocardiograms were recorded with
a standard resting 12-lead ECG at 50 mm/s. QT interval
analysis was done by a cardiologist who was blinded regarding
other information. QT intervals were corrected with Bazetts formula
(QTc=QT/R-R); QTc dispersion was calculated as the interlead
variability of QTc interval (QTc
dispersion=QTcmax-QTcmin).
During clamp administration, plasma glucose stabilized at 15 mmol/L, and plasma insulin showed a biphasic pattern of response, with an early rise at 10 minutes (327±89 pmol/L) followed by a gradual and sustained increase (456±120 pmol/L). QTc increased from 413±26 to 442±29 ms (P<0.05) at the end of the clamp administration, and QTc dispersion increased from 32±9 to 55±12 ms (P<0.01). Basal and clamped plasma glucose levels in the octreotide study were not significantly different from those of the control study; glucose-stimulated insulin responses were markedly reduced by octreotide (105±36 pmol/L at 10 minutes and 57±16 pmol/L at 120 minutes). QTc and QTc dispersion increases in the octreotide study did not differ from those recorded in the control study.
Acute hyperglycemia in normal subjects produces significant increases of QTc and QTc dispersion that persist during octreotide infusion, which suggests a minor role for insulin. Hyperglycemia may induce QT changes by increasing the cytosolic calcium content,3 by stimulating sympathetic activity,4 or both. These results may offer a novel mechanism through which hyperglycemia may add to the elevated cardiovascular risk of the diabetic patient.
| References |
|---|
|
|
|---|
2. Dekker JM, Feskens EJM, Schouten EG, Klootwijk P, Pool J, Kromhout D. The Zutphen Elderly Study: QTc duration is associated with levels of insulin and glucose tolerance. Diabetes. 1996;45:376380.[Abstract]
3. Ley J, Gavin JR III, Bowers JR. Diabetes mellitus: a disease of abnormal calcium metabolism? Am J Med. 1994;96:260273.[Medline] [Order article via Infotrieve]
4.
Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta
R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D. Glutathione
reverses systemic hemodynamic changes induced by
hyperglycemia in healthy subjects. Am J Physiol. 1995;268:E1167E1173.
Julius Centre for Patient-Oriented Research Utrecht, The Netherlands
| Introduction |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |